1 |
Liu J, Smith S, Wang C. Photothermal Attenuation of Cancer Cell Stemness, Chemoresistance, and Migration Using CD44-Targeted MoS(2) Nanosheets. Nano Lett 2023;23:1989-99. [PMID: 36827209 DOI: 10.1021/acs.nanolett.3c00089] [Reference Citation Analysis]
|
2 |
Pershina AG, Demin AM, Perekucha NA, Brikunova OY, Efimova LV, Nevskaya KV, Vakhrushev AV, Zgoda VG, Uimin MA, Minin AS, Malkeyeva D, Kiseleva E, Zima AP, Krasnov VP, Ogorodova LM. Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles. Colloids and Surfaces B: Biointerfaces 2023;221:112981. [DOI: 10.1016/j.colsurfb.2022.112981] [Reference Citation Analysis]
|
3 |
Mesquita BS, Fens MHAM, Di Maggio A, Bosman EDC, Hennink WE, Heger M, Oliveira S. The Impact of Nanobody Density on the Targeting Efficiency of PEGylated Liposomes. Int J Mol Sci 2022;23. [PMID: 36499301 DOI: 10.3390/ijms232314974] [Reference Citation Analysis]
|
4 |
Al-natour MA, Abdelrazig S, Ghaemmaghami AM, Alexander C, Kim D. Metabolic Signatures of Surface-Modified Poly(lactic- co -glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics. ACS Omega. [DOI: 10.1021/acsomega.2c01660] [Reference Citation Analysis]
|
5 |
Fletcher NL, Prior A, Choy O, Humphries J, Huda P, Ghosh S, Houston ZH, Bell CA, Thurecht KJ. Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance. Chem Commun (Camb) 2022. [PMID: 35726903 DOI: 10.1039/d2cc02443h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Zhang L, Cao C, Kaushik N, Lai RY, Liao J, Wang G, Ariotti N, Jin D, Stenzel MH. Controlling the Biological Behaviors of Polymer-Coated Upconverting Nanoparticles by Adjusting the Linker Length of Estrone Ligands. Biomacromolecules 2022. [PMID: 35584062 DOI: 10.1021/acs.biomac.2c00265] [Reference Citation Analysis]
|
7 |
Mills JA, Liu F, Jarrett TR, Fletcher NL, Thurecht KJ. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomater Sci 2022. [PMID: 35419582 DOI: 10.1039/d2bm00181k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
8 |
Yoong WC, Loke CF, Juan JC, Yusoff K, Mohtarrudin N, Tatsuma T, Xu Y, Lim TH. Alginate-enabled green synthesis of S/Ag1.93S nanoparticles, their photothermal property and in-vitro assessment of their anti-skin-cancer effects augmented by a NIR laser. Int J Biol Macromol 2022:S0141-8130(22)00078-2. [PMID: 35041888 DOI: 10.1016/j.ijbiomac.2022.01.062] [Reference Citation Analysis]
|
9 |
Li L, Yan X, Xia M, Shen B, Cao Y, Wu X, Sun J, Zhang Y, Zhang M. Nanoparticle/Nanocarrier Formulation as an Antigen: The Immunogenicity and Antigenicity of Itself. Mol Pharm 2022;19:148-59. [PMID: 34886673 DOI: 10.1021/acs.molpharmaceut.1c00704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
10 |
Ahmed SE, Fletcher NL, Prior AR, Huda P, Bell CA, Thurecht KJ. Development of targeted micelles and polymersomes prepared from degradable RAFT-based diblock copolymers and their potential role as nanocarriers for chemotherapeutics. Polym Chem . [DOI: 10.1039/d2py00257d] [Reference Citation Analysis]
|
11 |
Kappel C, Seidl C, Medina-Montano C, Schinnerer M, Alberg I, Leps C, Sohl J, Hartmann AK, Fichter M, Kuske M, Schunke J, Kuhn G, Tubbe I, Paßlick D, Hobernik D, Bent R, Haas K, Montermann E, Walzer K, Diken M, Schmidt M, Zentel R, Nuhn L, Schild H, Tenzer S, Mailänder V, Barz M, Bros M, Grabbe S. Density of Conjugated Antibody Determines the Extent of Fc Receptor Dependent Capture of Nanoparticles by Liver Sinusoidal Endothelial Cells. ACS Nano 2021;15:15191-209. [PMID: 34431291 DOI: 10.1021/acsnano.1c05713] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
12 |
Chen Y, Alba M, Tieu T, Tong Z, Minhas RS, Rudd D, Voelcker NH, Cifuentes-rius A, Elnathan R. Engineering Micro–Nanomaterials for Biomedical Translation. Adv NanoBio Res 2021;1:2100002. [DOI: 10.1002/anbr.202100002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
13 |
Ediriweera GR, Chen L, Yerbury JJ, Thurecht KJ, Vine KL. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives. Mol Pharm 2021;18:2142-60. [PMID: 34010004 DOI: 10.1021/acs.molpharmaceut.1c00297] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
14 |
Leiske MN, Lai M, Amarasena T, Davis TP, Thurecht KJ, Kent SJ, Kempe K. Interactions of core cross-linked poly(2-oxazoline) and poly(2-oxazine) micelles with immune cells in human blood. Biomaterials 2021;274:120843. [PMID: 33984635 DOI: 10.1016/j.biomaterials.2021.120843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
|
15 |
Cevaal PM, Ali A, Czuba-Wojnilowicz E, Symons J, Lewin SR, Cortez-Jugo C, Caruso F. In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design. ACS Nano 2021;15:3736-53. [PMID: 33600163 DOI: 10.1021/acsnano.0c09514] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
|
16 |
Ashford MB, England RM, Akhtar N. Highway to Success—Developing Advanced Polymer Therapeutics. Adv Therap 2021;4:2000285. [DOI: 10.1002/adtp.202000285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|